These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 8608226

  • 1. Abnormal inside-out signal transduction-dependent activation of glycoprotein IIb-IIIa in a patient with impaired pleckstrin phosphorylation.
    Gabbeta J, Yang X, Sun L, McLane MA, Niewiarowski S, Rao AK.
    Blood; 1996 Feb 15; 87(4):1368-76. PubMed ID: 8608226
    [Abstract] [Full Text] [Related]

  • 2. Combined defect in membrane expression and activation of platelet GPIIb--IIIa complex without primary sequence abnormalities in myeloproliferative disease.
    Kaplan R, Gabbeta J, Sun L, Mao GF, Rao AK.
    Br J Haematol; 2000 Dec 15; 111(3):954-64. PubMed ID: 11122160
    [Abstract] [Full Text] [Related]

  • 3. Glycoprotein IIb/IIIa inhibition attenuates platelet-activating factor-induced platelet activation by reducing protein kinase C activity.
    Hu H, Zhang W, Li N.
    J Thromb Haemost; 2003 Aug 15; 1(8):1805-12. PubMed ID: 12911597
    [Abstract] [Full Text] [Related]

  • 4. Association of CBFA2 mutation with decreased platelet PKC-theta and impaired receptor-mediated activation of GPIIb-IIIa and pleckstrin phosphorylation: proteins regulated by CBFA2 play a role in GPIIb-IIIa activation.
    Sun L, Mao G, Rao AK.
    Blood; 2004 Feb 01; 103(3):948-54. PubMed ID: 14525764
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A Glanzmann thrombasthenia-like phenotype caused by a defect in inside-out signaling through the integrin alpha(IIb)beta3.
    Tomiyama Y, Shiraga M, Kinoshita S, Ambo H, Kurata Y, Matsuzawa Y, Kunicki TJ.
    Thromb Haemost; 1998 Nov 01; 80(5):735-42. PubMed ID: 9843164
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Human platelet signaling defect characterized by impaired production of inositol-1,4,5-triphosphate and phosphatidic acid and diminished Pleckstrin phosphorylation: evidence for defective phospholipase C activation.
    Yang X, Sun L, Ghosh S, Rao AK.
    Blood; 1996 Sep 01; 88(5):1676-83. PubMed ID: 8781423
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The P2Y(12) receptor induces platelet aggregation through weak activation of the alpha(IIb)beta(3) integrin--a phosphoinositide 3-kinase-dependent mechanism.
    Kauffenstein G, Bergmeier W, Eckly A, Ohlmann P, Léon C, Cazenave JP, Nieswandt B, Gachet C.
    FEBS Lett; 2001 Sep 14; 505(2):281-90. PubMed ID: 11566191
    [Abstract] [Full Text] [Related]

  • 12. Prevention of platelet glycoprotein IIb/IIIa activation by 3,4-methylenedioxy-beta-nitrostyrene, a novel tyrosine kinase inhibitor.
    Wang WY, Wu YC, Wu CC.
    Mol Pharmacol; 2006 Oct 14; 70(4):1380-9. PubMed ID: 16837624
    [Abstract] [Full Text] [Related]

  • 13. Induction of fibrinogen binding and platelet aggregation as a potential intrinsic property of various glycoprotein IIb/IIIa (alphaIIbbeta3) inhibitors.
    Peter K, Schwarz M, Ylänne J, Kohler B, Moser M, Nordt T, Salbach P, Kübler W, Bode C.
    Blood; 1998 Nov 01; 92(9):3240-9. PubMed ID: 9787160
    [Abstract] [Full Text] [Related]

  • 14. Glycoprotein IIb Leu214Pro mutation produces glanzmann thrombasthenia with both quantitative and qualitative abnormalities in GPIIb/IIIa.
    Grimaldi CM, Chen F, Wu C, Weiss HJ, Coller BS, French DL.
    Blood; 1998 Mar 01; 91(5):1562-71. PubMed ID: 9473221
    [Abstract] [Full Text] [Related]

  • 15. Von Willebrand factor can support platelet aggregation via interaction with activated GPIIb-IIIa and GPIb.
    Naimushin YA, Mazurov AV.
    Platelets; 2004 Nov 01; 15(7):419-25. PubMed ID: 15745313
    [Abstract] [Full Text] [Related]

  • 16. Synergistic outside-in regulation of platelet activation by GPIIb/IIIa ligand-induced conformation and oligomerization.
    Wang XF, Liu F, Morris SA, Carroll RC.
    Thromb Res; 2001 Nov 15; 104(4):239-47. PubMed ID: 11728525
    [Abstract] [Full Text] [Related]

  • 17. Coordinated signaling through both G12/13 and G(i) pathways is sufficient to activate GPIIb/IIIa in human platelets.
    Dorsam RT, Kim S, Jin J, Kunapuli SP.
    J Biol Chem; 2002 Dec 06; 277(49):47588-95. PubMed ID: 12297512
    [Abstract] [Full Text] [Related]

  • 18. Differential inhibition of fibrinogen binding to agonist- and RGDS peptide-activated states of GPIIb-IIIa by an anti-GPIIIa monoclonal antibody, PMA5.
    Nakatanl S, Hato T, Minamoto Y, Fujita S.
    Thromb Haemost; 1996 Dec 06; 76(6):1030-7. PubMed ID: 8972028
    [Abstract] [Full Text] [Related]

  • 19. Human platelet activation is inhibited by the occupancy of glycoprotein IIb/IIIa receptor.
    Padoin E, Alexandre A, Cavallini L, Polverino de Laureto P, Rao GH, Doni MG.
    Arch Biochem Biophys; 1996 Sep 15; 333(2):407-13. PubMed ID: 8809080
    [Abstract] [Full Text] [Related]

  • 20. Protein kinase C- and calcium-regulated pathways independently synergize with Gi pathways in agonist-induced fibrinogen receptor activation.
    Quinton TM, Kim S, Dangelmaier C, Dorsam RT, Jin J, Daniel JL, Kunapuli SP.
    Biochem J; 2002 Dec 01; 368(Pt 2):535-43. PubMed ID: 12215172
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.